HSBC HOLDINGS PLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2021$35,000
-30.0%
12,888
-34.6%
0.00%
Q4 2020$50,000
+31.6%
19,693
+68.6%
0.00%
Q2 2020$38,000
+22.6%
11,681
-10.0%
0.00%
Q1 2020$31,000
-72.3%
12,979
-38.0%
0.00%
Q4 2016$112,00020,9350.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders